Sunday , October 17 2021

Salute

Chronic diseases here are ROMA PAY news

MILAN – The first biosimilar adalimumab appears in Italy for the treatment of adult severe chronic inflammatory diseases such as moderate to severe rheumatoid arthritis, psoriatic arthritis, severe active ankylosing spondylitis, moderate …

Read More »